Dr Andrew Turner
Postdoctoral Researcher
Andrew is a researcher in the Digital Ethics Lab at the Oxford Internet Institute. He is a philosopher with training in social science research methods working at the intersection of social science, data science and healthcare. Andrew’s research focuses on bringing philosophical perspectives to understanding the socio-technical challenges of sharing and protecting biomedical data.
Prior to joining the OII, Andrew was a Senior Research Associate in the Data to Knowledge group at the University of Bristol, where he mainly worked on the transdisciplinary DataSHIELD project (open source software to facilitate secure data analysis in the biomedical sciences: www.datashield.ac.uk). Andrew also maintains research interests related to his doctoral work and continues to publish about the philosophy of evidence-based medicine and placebos.
Research Interests
Science & Technology Studies, Data science, Research infrastructure, Research software engineering, placebos
Conference papers
- (2017) "Privacy protected text analysis in DataSHIELD", International Journal for Population Data Science. Swansea University. 1 (1).
- (2017) "Disclosure and Data Linkage", International Journal for Population Data Science. Swansea University. 1 (1).
- (2017) "Privacy protected graphical functionality in DataSHIELD", International Journal for Population Data Science. Swansea University. 1 (1).
Journal articles
- (2017) "Evaluating the UK House of Commons Science and Technology Committee?s position on the implausible effectiveness of homeopathic treatments", Theoretical Medicine and Bioethics. 38 (4) 335-352.
- (2017) "DataSHIELD – New Directions and Dimensions", Data Science Journal. 16.
- (2017) "The ECOUTER methodology for stakeholder engagement in translational research", BMC Medical Ethics. 18 (1) 24.
- (2016) "Problematic placebos in physical therapy trials", Journal of Evaluation in Clinical Practice. 22 (4) 598-602.
- (2016) "Digital methodology to implement the ECOUTER engagement process", F1000Research. 5 1307.
- (2016) "International Data Sharing in Practice: New Technologies Meet Old Governance", Biopreservation and Biobanking. 14 (3) 231-240.
- (2016) "Digital Methodology to implement the ECOUTER engagement process", F1000Research. 5 1307.
- (2015) "Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy", Trials. 16 (1) 394.
- (2015) "Stakeholder views about participating in paediatric biobanks: a narrative review", International Journal of Humanities and Social Sciences. 2 71-85.
- (2014) "DataSHIELD: taking the analysis to the data, not the data to the analysis", International Journal of Epidemiology. 43 (6) 1929-1944.
- (2014) "DataSHIELD: An Ethically Robust Solution to Multiple-Site Individual-Level Data Analysis", Public Health Genomics. 18 (2) 87-96.
- (2014) "Fracking on YouTube: Exploring Risks, Benefits and Human Values", Environmental Values. 23 (5) 501-527.
- (2014) "Response to Miles and Mezzich “Medicine in crisis and a crisis in semantics”", European Journal for Person Centered Healthcare. 2 83-84.
- (2013) "Exploratory evaluation of variation in statin take up among high risk patients in Nottingham City", Public Health. 127 (10) 958-960.
- (2013) "Biobank Economics and the Commercialization Problem", Spontaneous Generations. 7 (1) 69-80.
- (2012) "‘Placebos’ and the logic of placebo comparison", Biology & Philosophy. 27 (3) 419-432.
- (2011) "Book Review: Philosophy of the Social Sciences", Perspectives. 3 89-96.
- (2008) "Capitalizing hope: the commercial development of umbilical cord blood stem cell banking", New Genetics and Society. 27 (2) 127-143.
Theses / Dissertations
- (2012) Evidence-based medicine, placebos and the homeopathy controversy.